IntrinsicIntrinsic
← Scroll for more →

Financial Statements — DRTS

Balance Sheet

(in millions USD)
MetricQ4 2025Q2 2025Q4 2024Q2 2024Q4 2023Q2 2023Q4 2022Q4 2021
Cash & Equivalents12.2011.7013.722.7612.660.865.8423.24
Short-term Investments60.9268.0045.8868.2769.1392.6798.69--
Total Current Assets78.3085.7864.2375.2585.7696.06106.4832.64
Property, Plant & Equipment19.6617.2913.9312.3512.807.557.477.55
Total Non-current Assets*27.3525.1821.9820.8021.6315.1513.679.57
Total Assets105.65110.9586.2096.05107.39111.21120.1542.22
Accounts Payable--------2.571.791.421.20
Total Current Liabilities10.518.168.686.467.105.424.344.41
Long-term Debt------5.250.01------
Total Non-current Liabilities*18.0516.1814.8615.5815.8113.2310.1518.62
Total Liabilities28.5524.3323.5422.0322.9118.6414.4923.03
Retained Earnings(190.14)(166.31)(147.51)(131.11)(115.76)(103.48)(86.60)(52.84)
Total Stockholder Equity77.1086.6262.6774.0284.4892.56105.66(34.78)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023
Research & Development14.1813.3112.26
Selling, General & Admin3.863.033.63
Operating Income(18.96)(17.48)(16.81)
Pretax Income(18.64)(15.35)(16.83)
Tax Provision0.160.000.05
Net Income(18.80)(15.35)(16.88)
Basic EPS(0.25)(0.22)(0.24)
Diluted EPS(0.25)(0.22)(0.24)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023
Operating Cash Flow(14.61)(12.80)(9.92)
Capital Expenditures3.210.120.59
Free Cash Flow*(17.82)(12.92)(10.51)
Investing Cash Flow(24.19)2.874.97
Financing Cash Flow36.760.030.00
← Scroll for more columns →

* Derived from reported values